ESR1 and breast carcinoma: Only nine H-Bs (AURKA, HSP90AA1, CDK4, CCND1, CDH1, ESR1, MAPK3, PTPN11, and RPS6KB1) showed a significant association between expression levels and the overall survival time of patients with breast cancer (Figure 6(b)).